November 23, 2015 · STOCK Act disclosure
Representative James B. Renacci (Republican-OH) bought Axion Pharmaceuticals Incorporated, a stock transaction, valued at $1,000 - $15,000. The trade took place on November 23, 2015 and was disclosed on December 7, 2015 (owner: Self). Members of Congress must report such transactions within 45 days under the STOCK Act.